Intervention

Standard of care immune checkpoint inhbitors

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting1

Common conditions3

Lead sponsors shown1

Clinical trials

1 shown

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLCNCT05332925 · 2022-07-21

RECRUITING

Common conditions

Lung Cancer1 NSCLC1 NSCLC Stage IV1

Leading sponsors

Jun Zhang, MD, PhD1

Trial status mix

RECRUITING1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.